Results 201 to 210 of about 316,954 (250)

Nano‐Backpack Engineered Probiotics with Reactive Oxygen Species–Responsive Tungsten Release for Synergistic Therapy of Inflammatory Bowel Disease

Advanced Science, EarlyView.
An integrated probiotic system is engineered to execute a programmed therapeutic cascade against inflammatory bowel disease. Upon pathological signals, the system sequentially performs ROS scavenging, tungsten release, and selective pathogen suppression, thereby breaking the oxidative stress–dysbiosis cycle to remodel gut microbiota and reinforce ...
Yang Yang, Liucan Wang, Guoqing Chen, Yuanling Zhang, Jiarui Shi, Wenzhe Fan, Min Yu, Jixi Zhang, Hua Yang   +8 more
wiley   +1 more source

Microbiota-derived metabolites and cardiovascular implications in Inflammatory Bowel Disease (IBD). [PDF]

Mol Med
Olić I, Pavlović N, Kumrić M, Šantić R, Bratanić A, Božić J.   +5 more
europepmc   +1 more source

Current approaches to disease severity and therapy effectiveness assessment in patients with inflammatory bowel disease. [PDF]

World J Gastrointest Pharmacol Ther
Loktionov A.
europepmc   +1 more source

Association between physical activity and inflammatory bowel disease: a prospective cohort study. [PDF]

Front Public Health
Wei Y, He B, Zhang G, Chen H, Li T.
europepmc   +1 more source

Mental Health Disorders in Pediatric Inflammatory Bowel Disease: Epidemiology, Mechanisms, and Interventions. [PDF]

J Inflamm Res
Liu Y, Hu Y, Zheng J, Wu Z.
europepmc   +1 more source

School and School-Related Experiences of Children and Adolescents With Inflammatory Bowel Disease: A Scoping Review. [PDF]

Child Care Health Dev
Rice J, Wilkinson C.
europepmc   +1 more source

Prenatal Exposure to Acid-Suppressive Medications and Incident Risk of Inflammatory Bowel Disease in Children.

JAMA Netw Open
Oh J, Park J, Kim H, Jo H, Lee K, Jo Y, Hong S, Lee S, Woo S, Hwang Y, Lee J, Kim TH, Lee H.   +12 more
europepmc   +1 more source